Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04789746
Other study ID # STU00209443
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date February 20, 2019
Est. completion date December 2024

Study information

Verified date March 2024
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Barriers to keeping and maintaining fitness as a young person with a disability exist across many domains of access to community locations such as fitness centers, so looking outside of these establishments may be necessary to advance fitness. This study is aimed at piloting a program that would address some of these barriers by hosting a modified after school running program with an underserved population in an accessible way. There is a second option to participate outside of school.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 25
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria: - a medical diagnosis (for example, cerebral palsy) that causes them mobility limitations Exclusion Criteria: - concurrent medical condition that would make exercise unsafe, - are unable to follow simple commands - have behaviors that would potentially compromise safety of fellow runners or caregivers

Study Design


Intervention

Behavioral:
adapted Chicago Run running program
The intervention being piloted is a 6-8 week running program modified from a running curriculum designed for school-aged children. The children will use a RaceRunner device to facilitate their participation, but this device is not explicitly evaluated in this study. Depending on transportation, they may be given access to the device in their home or school between sessions after it has been fit for them. If given access, guardians will be instructed on care and usage.

Locations

Country Name City State
United States Northwestern University Chicago Heights Illinois

Sponsors (4)

Lead Sponsor Collaborator
Northwestern University American Academy of Cerebral Palsy and Developmental Medicine, Chicago Run, Spencer Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Goal attainment scale a tool designed to standardize the setting and scaling of goals in a way that allows for both improvement and regression as a result of intervention. at 8 weeks.
Primary 6 min walk test Participant will walk as far as they can in 6 minutes, as a measure of endurance baseline
Primary 6 min walk test Participant will walk as far as they can in 6 minutes, as a measure of endurance at 8 weeks
Primary 30 second walk test Participant will walk as fast as they can for 30 seconds, as a measure of speed. baseline
Primary 30 second walk test Participant will walk as fast as they can for 30 seconds, as a measure of speed. at 8 weeks
Primary Resting heart rate Participant heart rate after 5 minutes of quiet sitting baseline
Primary Resting heart rate Participant heart rate after 5 minutes of quiet sitting at 8 weeks
Secondary Surveys Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength baseline
Secondary Surveys Participants and their parents will answer questions about baseline level of activity, their perception of themselves, and areas of personal strength at 8 weeks
Secondary Selective Control Assessment of the Lower Extremity (SCALE) a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity. Min score=0; max score=16, a higher score is a better outcome baseline
Secondary Selective Control Assessment of the Lower Extremity (SCALE) a method of assessing the ability of a participant to isolate motion to an individual joint of the lower extremity Min score=0; max score=16, a higher score is a better outcome at 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2
Completed NCT02897024 - A Comparison: High Intense Periodic vs. Every Week Therapy in Children With Cerebral Palsy (ACHIEVE) N/A